InvestorsHub Logo
Followers 30
Posts 3030
Boards Moderated 0
Alias Born 03/01/2004

Re: BioBS2012 post# 315148

Monday, 10/23/2017 9:41:16 PM

Monday, October 23, 2017 9:41:16 PM

Post# of 346385
In it's usual lack of transparency we do not know much about the relationship between PPHM and MSK/NCCN.
We give them 2 million they do small test to probe the IP. Then what, PPHM mentioned partnering, but, seems like no takers that we know of.

What next, do we give MSK 10 to 15 million to initiate Phase1 trials, where do they go with the IP and no takers.

Who is paying the bills.
What would MSK say if they were informed there is no money. Would they walk away from PS. Would they find a way to include it in Pd-1 trials with the right Biomarkers.

Why don't shareholders know the answers.

Guns have now surpassed car accidents in cause of deaths in the USA.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News